• Explore /
  • Poster
  • / Phase I dose-escalation results of prostate-specific membrane antigen-targeted radionuclide therapy (PSMA-TRT) with alpha-radiolabeled antibody <sup>225</sup>Ac-J591 and beta-radioligand <sup>177</sup>Lu-PSMA I&T.

Phase I dose-escalation results of prostate-specific membrane antigen-targeted radionuclide therapy (PSMA-TRT) with alpha-radiolabeled antibody 225Ac-J591 and beta-radioligand 177Lu-PSMA I&T.

Abstract Video & Slides Poster

Authors

Scott Tagawa

Scott T. Tagawa

Weill Cornell Medicine, Division of Hematology & Medical Oncology, NewYork-Presbyterian Hospital, New York, NY

Scott T. Tagawa , Michael Philip Sun , Jones T. Nauseef , Charlene Thomas , Sandra Huicochea Castellanos , Joseph Earl Thomas , Zachary Davidson , Judith Stangl-Kremser , Mahelia Bissassar , Jessica Palmer , Angela Tan , Amie Patel , Ana M. Molina , Cora N. Sternberg , David M. Nanus , Joseph Osborne , Neil Harrison Bander

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Genitourinary Cancer—Prostate, Testicular, and Penile

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Prostate Cancer– Advanced/Castrate-Resistant

Clinical Trial Registration Number

NCT04886986

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 5018)

DOI

10.1200/JCO.2023.41.16_suppl.5018

Abstract #

5018

Poster Bd #

112

Abstract Disclosures

Similar Posters

First Author: Scott T. Tagawa

First Author: Daniel Peter Petrylak

First Author: Daniel Peter Petrylak

First Author: Tanya B. Dorff